Intersect ENT Appoints Christine Kowalski Chief Operations Officer

Christine Kowalski has joined Intersect ENT (NASDAQ: [[ticker:XENT]]) as chief operations officer. Kowalski most recently served as vice president of supply chain strategy at Johnson & Johnson (NYSE: [[ticker:JNJ]]).

Menlo Park, CA-based Intersect had previously disclosed that chief operating officer Rich Kaufman will retire in early 2019. The company said he will work with Kowalski as she her transitions to her new role. In other moves, Intersect general manager Susan Stimson has taken on the new role of chief strategy officer. Intersect develops and sells medical devices that provide targeted delivery of a drug for conditions affecting the ear, nose, and throat.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan